Shopping Cart
- Remove All
Your shopping cart is currently empty
Prinomastat hydrochloride is a orally active inhibitor of metalloproteinase (MMP)(MMP-1, MMP-3 and MMP-9 with IC50s of 79, 6.3 and 5.0 nM , respectively),with Antitumor avtivity.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,070 | 1-2 weeks | |
| 50 mg | $1,390 | 1-2 weeks | |
| 100 mg | $2,120 | 1-2 weeks |
| Description | Prinomastat hydrochloride is a orally active inhibitor of metalloproteinase (MMP)(MMP-1, MMP-3 and MMP-9 with IC50s of 79, 6.3 and 5.0 nM , respectively),with Antitumor avtivity. |
| Targets&IC50 | MMP2:0.05 nM (Ki), MMP9:5 nM, MMP9:0.26 nM (Ki), MMP13:0.3 nM (Ki), MMP13:6.3 nM, Collagenases 1:0.03 nM (Ki), MMP1:79 nM |
| In vitro | Prinomastat inhibits Wnt1-induced MMP-3 production. Reversal of Wnt1-induced EMT and β-catenin transcriptional activity by Prinomastat[1]. |
| In vivo | Prinomastat has good tumour growth inhibition, with a short T1/2 of 1.6 hours[1]. |
| Synonyms | KB-R9896 hydrochloride, AG3340 hydrochloride |
| Molecular Weight | 459.97 |
| Formula | C18H22ClN3O5S2 |
| Cas No. | 1435779-45-5 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (217.41 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.